SANGBOCo상보
027580 · KOSDAQ · ₩027580 · 상보
₩1,600▼ ₩70 (4.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩50B | ₩54B | ₩66B | ₩67B | ₩133B |
| Cost of sales | ₩44B | ₩43B | ₩51B | ₩52B | ₩113B |
| Gross profit | ₩6.5B | ₩11B | ₩15B | ₩15B | ₩20B |
| Operating income | −₩8.9B | −₩8B | ₩2.3B | ₩2.5B | ₩3.2B |
| Net income | −₩13B | −₩11B | ₩438M | ₩8.8B | ₩2B |
| Net income to shareholders | −₩13B | −₩11B | ₩438M | ₩8.8B | ₩2B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩94B | ₩105B | ₩118B | ₩112B | ₩133B |
| Current assets | ₩59B | ₩68B | ₩74B | ₩71B | ₩93B |
| Cash and equivalents | ₩5.5B | ₩9.1B | ₩10B | ₩22B | ₩25B |
| Total liabilities | ₩51B | ₩54B | ₩55B | ₩47B | ₩76B |
| Current liabilities | ₩42B | ₩46B | ₩48B | ₩41B | ₩71B |
| Borrowings | ₩34B | ₩36B | ₩36B | ₩32B | ₩42B |
| Total equity | ₩43B | ₩51B | ₩63B | ₩66B | ₩57B |
| Shareholders' equity | ₩43B | ₩51B | ₩62B | ₩66B | ₩57B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩7.2B | ₩433M | ₩7.8B | ₩614M | ₩8.2B |
| Capital spending | ₩604M | ₩824M | ₩1.7B | ₩1.2B | ₩3.7B |
| Free cash flow | −₩7.8B | −₩390M | ₩6.1B | −₩585M | ₩4.4B |
Consolidated where available. Amounts in won.
Also known as: SANGBOCo / 상보 / 027580 / KRX:027580
Source: KRX statistical information